Predict your next investment

Growth Equity
healthquestcapital.com

See what CB Insights has to offer

Investments

41

Portfolio Exits

10

Funds

5

Service Providers

1

About HealthQuest Capital

HealthQuest Capital makes early growth investments in commercial-stage healthcare companies that are improving both patient outcomes and healthcare economics. Investments focus on medical products, diagnostics, healthcare IT and technology-enabled healthcare services. The HealthQuest investing team includes deep operational, clinical and scientific expertise and worldwide relationships throughout the healthcare industry that can be leveraged to add value to portfolio companies. HealthQuest Capital is headquartered in Belmont, CA with offices in Tampa, FL.

HealthQuest Capital Headquarter Location

3000 Sand Hill Road Building 4, Suite 250

Menlo Park, California, 94025,

United States

650-681-8424

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing HealthQuest Capital

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned HealthQuest Capital in 1 CB Insights research brief, most recently on Jan 11, 2021.

Latest HealthQuest Capital News

RareCyte Secures $24M Financing

Sep 14, 2021

RareCyte, Inc., a Seattle, WA-based Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, raised $24M in financing.Arboretum Ventures led the financing joined by other new investors F-Prime Capital, Logos Capital, and Agilent Technologies.Existing investors participating in the financing included HealthQuest Capital, 5AM Ventures, and Company founder Ron Seubert.Jan Garfinkle, Arboretum Managing Partner, joined the RareCyte Board of Directors along with Robert Weisskoff, Ph.D., Partner at F-Prime Capital.Led by Joe Victor, President and CEO, RareCyte offers Precision Biologyâ„¢ solutions focused on multiplexed analysis of cells and tissue with applications in both research and clinical diagnostics. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.

HealthQuest Capital Investments

41 Investments

HealthQuest Capital has made 41 investments. Their latest investment was in RareCyte as part of their Private Equity - IV on September 9, 2021.

CBI Logo

HealthQuest Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/9/2021

Private Equity - IV

RareCyte

$24M

No

3

7/26/2021

Series B

83bar

Yes

1

6/2/2021

Series C

Thirty Madison

$140M

Yes

4

1/15/2021

Secondary Market

Subscribe to see more

$99M

Subscribe to see more

10

10/8/2020

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/9/2021

7/26/2021

6/2/2021

1/15/2021

10/8/2020

Round

Private Equity - IV

Series B

Series C

Secondary Market

Series D

Company

RareCyte

83bar

Thirty Madison

Subscribe to see more

Subscribe to see more

Amount

$24M

$140M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

1

4

10

10

HealthQuest Capital Portfolio Exits

10 Portfolio Exits

HealthQuest Capital has 10 portfolio exits. Their latest portfolio exit was Bardy Diagnostics on January 19, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/19/2021

Acq - Pending

$991

14

1/5/2021

Acquired

$991

17

10/1/2020

IPO

$991

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

1/19/2021

1/5/2021

10/1/2020

00/00/0000

00/00/0000

Exit

Acq - Pending

Acquired

IPO

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

14

17

1

10

10

HealthQuest Capital Fund History

5 Fund Histories

HealthQuest Capital has 5 funds, including HealthQuest Ajax III SPV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/30/2019

HealthQuest Ajax III SPV

$40.2M

1

5/31/2019

HealthQuest Ajax II SPV

Subscribe to see more

$99M

10

4/3/2019

HealthQuest Partners III

Subscribe to see more

$99M

10

3/15/2016

HealthQuest Partners II

Subscribe to see more

$99M

10

8/19/2014

HealthQuest Capital I

Subscribe to see more

$99M

10

Closing Date

10/30/2019

5/31/2019

4/3/2019

3/15/2016

8/19/2014

Fund

HealthQuest Ajax III SPV

HealthQuest Ajax II SPV

HealthQuest Partners III

HealthQuest Partners II

HealthQuest Capital I

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$40.2M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

HealthQuest Capital Service Providers

1 Service Provider

HealthQuest Capital has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

HealthQuest Capital Team

2 Team Members

HealthQuest Capital has 2 team members, including current Founder, Managing Partner, Garheng Kong.

Name

Work History

Title

Status

Garheng Kong

Founder, Managing Partner

Current

Manfred Yu

Chief Financial Officer

Current

Name

Garheng Kong

Manfred Yu

Work History

Title

Founder, Managing Partner

Chief Financial Officer

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.